The biotechnology space is a booming one, with a mix of technological and medical innovation leading to advanced treatments of incredible value. Not only are the biotechnology companies of today bringing improved quality and extended length of life to patients, they’re also bringing incredibly profitable opportunities to investors. When looking into a potential biotechnology investment, … Read more
Hemispherx Biopharma (NYSEAMERICAN: HEB), a research and development biotechnology company, is grabbing the attention of the investing community, and for good reason. Not only does the company have revenue-generating products, but its flagship candidate, Ampligen, is showing incredible promise. What Is Hemispherx Biopharma? Headquartered in Ocala, Florida, Hemispherx Biopharma is a research and development immuno-pharma … Read more
Hemispherx BioPharma, Inc (NYSEAMERICAN: HEB) is having an incredibly strong start to the trading session this morning, and for good reason. The comapny announced significant progress in a clinical oncology program. Read my full report on HEB here! As you could imagine, the news excited investors, pushing the stock on a run for the top. … Read more
Hemispherx BioPharma, Inc (NYSEMKT: HEB) is having an incredibly strong day in the market today, and for good reason. The company recently announced an update with regard to a key clinical development. Of course, this led to excitement among investors who are sending the stock toward the sky. As is usually the case, our partners … Read more